Chronic conditions and multimorbidity in a primary care population: a study in the Swiss Sentinel Surveillance Network (Sentinella)

Markus Gnädinger, Lilli Herzig, Alessandro Ceschi, Dieter Conen, Alfred Staehelin, Marco Zoller, Milo A Puhan, Markus Gnädinger, Lilli Herzig, Alessandro Ceschi, Dieter Conen, Alfred Staehelin, Marco Zoller, Milo A Puhan

Abstract

Objectives: To provide estimates of the prevalence of chronic conditions in Swiss primary care.

Methods: In total, 175 general practitioners (GP) or pediatricians (PED) reporting to the Swiss Sentinel Surveillance Network collected morbidity data.

Results: In 26,853 patient contacts, mean (± SD) age was 55.8 ± 21.6 or 6.1 ± 5.7 years (in GPs vs. PEDs, respectively) and 47% were males. In GP patients, median Thurgau Morbidity Index was 2 (IQR 1-3). The median numbers of chronic conditions and permanently used prescribed drugs were 2 (0-5) and 2 (1-4), respectively; in PEDs medians were 0. Out of all patients, 16.7 and 7.0% of the PED patients were hospitalized during the previous year; patients cared by family/proxies or community nurses were hospitalized significantly more often than patients living in homes (50.1 vs. 35.4%, OR 1.41, p < 0.001). Out of patients over 80 years of age, 51.5% were care dependent and 45.5% of the patients over 90 years were living in homes for the elderly.

Conclusions: In a representative sample of Swiss primary care patients, a substantial part shows multimorbidity with a high prevalence of chronic diseases, multiple drug treatment, and care dependency. These data may serve to be compared with other patient groups or other primary care systems. Trial registration www.clinicaltrials.gov NCT0229537, national study registry www.kofam.ch SNCTP000001207.

Trial registration: ClinicalTrials.gov NCT02295371.

Keywords: Care dependency; Drug treatment; Hospitalization; Morbidity; Primary health care; Switzerland.

Conflict of interest statement

Conflict of interest

The authors declare that they have no financial conflicts of interest regarding this study.

Ethical approval

The ethical committee of the Canton of Zurich waived our study since they decided that it did not need formal approval according to the regulations of the law on human research in Switzerland (KEK-ZH 2014-0400).

Informed consent

Informed consent was not deemed since the data were fully anonymous.

Figures

Fig. 1
Fig. 1
Thurgau Morbidity Index* (TMI) values, percent % (MIPC study, Switzerland 2015). *The index values denote: “0” healthy, “1” premorbid, “2” one or two mild-to-moderate conditions, “3” three and more mild-to-moderate conditions, “4” one severe and less than three mild-to-moderate conditions, “5” one severe and three or more mild-to-moderate conditions, “6” two or more severe conditions. Graduations denote the entire class
Fig. 2
Fig. 2
Number of prescribed drugs* regularly taken, percent values (%) (MIPC study, Switzerland 2015). *Graduations denote the entire class
Fig. 3
Fig. 3
Care dependency* by age groups (percent values %, adult patients only) (MIPC study, Switzerland 2015). *Graduations denote the entire class
Fig. 4
Fig. 4
Comparison of Thurgau Morbidity Index (≥ 3) or chronic conditions (≥ 3) with literaturea (Fortin et al. , see figure 3 of that article, with permission) (MIPC study, Switzerland 2015). aThis review collected consultation-derived information in primary care settings from several studies and compared the prevalence of three or more chronic conditions by age groups. However, the Swiss FIRE data (Rizza et al. 2012) were not consultation- but registry-based

References

    1. Bähler C, Huber CA, Brüngger B, Reich O. Multimorbidity, health care utilization and costs in an elderly community-dwelling population: a claims data based observational study. BMC Health Serv Res. 2015;15:23. doi: 10.1186/s12913-015-0698-2.
    1. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of mulltimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37–43. doi: 10.1016/S0140-6736(12)60240-2.
    1. Blozik E, Rapold R, von Overbeck J, Reich O. Polypharmacy and potentially inappropriate medication in the adult, community-dwelling population in Switzerland. Drugs Aging. 2013;30:561–568. doi: 10.1007/s40266-013-0073-0.
    1. Bodenheimer T, Chen E, Bennett HD. Confronting the growing burden of chronic disease: can the U.S. health care workforce do the job? Health Aff. 2009;28(1):64–74. doi: 10.1377/hlthaff.28.1.64.
    1. Bodenmann P, Favrat B, Wolff H, Guessous I, Panese F, Herzig L, Bischoff T, Casillas A, Golano T, Vaucher P. Screening primary-care patients forgoing health care for economic reasons. PLoS ONE. 2015;9(4):e94006. doi: 10.1371/journal.pone.0094006.
    1. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases implications for pay for performance. JAMA. 2005;294(6):716–724. doi: 10.1001/jama.294.6.716.
    1. De Pietro C, Camenzind P, Sturny I, Crivelli L, Edwards-Garavoglia S, Spranger A, Wittenbecher F, Quentin W. Switzerland: health system review. Health Syst Transit Eur Obs Health Syst Policies. 2015;17(4):1–288.
    1. Déruaz-Luyet A, N’Goran AA, Senn N, Bodenmann P, Pasquier J, Widmer D, Tandjung R, Rosemann T, Frey P, Streit S, Zeller A, Haller DM, Excoffier S, Burnand B, Herzig L. Multimorbidity in primary care: protocol of a national cross-sectional study in Switzerland. BMJ Open. 2017;5:e00091165.
    1. Eliot RA, Lee CY, Beanland C, Vakil K, Goeman D. Medicines management, medication errors and adverse medication events in older people referred to a community nursing service: a retrospective observational study. Drugs Real World Outcomes. 2016;3:13–24. doi: 10.1007/s40801-016-0065-6.
    1. Equator, the Network (2018). . Accessed 28 Jan 2018
    1. Evans DC, Cook CH, Christy JM, Murphy CV, Gerlach AT, Eifermann D, Lindsey DE, Whitmill ML, Papadimos TJ, Beery PR, II, Steinberg SM, Stawicki PA. Comorbidity-polypharmacy scoring facilitates outcome prediction in older trauma patients. J Am Getiatr Soc. 2012;60:1465–1470. doi: 10.1111/j.1532-5415.2012.04075.x.
    1. Excoffier S, Herzig L, N’Goran A, Déruaz-Luyet A, Haller D. Prevalence of multimorbidity in general practice: a cross-sectional study within the Swiss Sentinel Surveillance system (Sentinella) BMJ open. 2017 doi: 10.1136/bmjopen-2017-019616.
    1. Federal Office of Public Health (2015). Nichtübertragbaren Krankheiten mit vereinten Kräften vorbeugen. Media release August 4th 2015.
    1. Federal Office of Public Health (2018). Homepage of the Sentinella reporting system. . Accessed 28 Dec 2018
    1. Fischer JE, Peltenburg M, Kühne R, Achermann C. Der TMI auf dem Prüfstand: Güte und Probleme der Kostenvorhersage anhand einfach kodierbarer Patientenmorbidität. Schweizerische Ärztezeitung. 2007;88(26):1156–1165. doi: 10.4414/saez.2007.12818.
    1. Fortin M, Stewart M, Poitras ME, Almirall J, Maddocks H. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012;2012(10):142–151. doi: 10.1370/afm.1337.
    1. FSO, Swiss Federal Statistical office (2018). Medico-social care in institutions and at home in 2016. . Accessed 29 Jan 2018
    1. Gijsen R, Hoeymans N, Schellevis FG, Ruwaard D, Satariano WA, van den Boos GAM. Causes and consequences of comorbidity: a review. J Clin Epidemiol. 2001;54:661–674. doi: 10.1016/S0895-4356(00)00363-2.
    1. Gnädinger M, Ceschi A, Conen D, Herzig L, Puhan MA, Staehelin A, Zoller M. Medication incidents in primary care medicine: protocol of a study by the Swiss Federal Sentinel Reporting System. BMJ Open. 2015;5(4):e007773. doi: 10.1136/bmjopen-2015-007773.
    1. Gnädinger M, Conen D, Herzig L, Puhan MA, Staehelin A, Zoller M, Ceschi A (2017) Medication incidents in primary care medicine: a prospective study in the Swiss Sentinel Surveillance Network (Sentinella). BMJ open.
    1. Hasler S, Senn O, Rosemann T, Neuner-Jehle S. Effect of a patient-centered drug review on polypharmacy in primary care patients: study protocol for a cluster-randomized controlled trial. BMC Trials. 2015;16:380. doi: 10.1186/s13063-015-0915-7.
    1. Häusler N, Hämming O, Bopp M. Impact of parenthood, informal caregiving and its combination on self-rated health—a population-based study in Switzerland. Popul Ageing. 2017 doi: 10.1007/s12062-017-9208-0.
    1. Holmes M, Garver M, Albrecht L, Arabi S, Pham TN. Comparison of two comorbidity scoring systems for older adults with traumatic injuries. J Am Coll Surg. 2014;219:631–637. doi: 10.1016/j.jamcollsurg.2014.05.014.
    1. IBM SPSS homepage (2018). . Accessed 28 Jan 2018
    1. Housley BC, Stawicki SPA, Evans DC, Jones C. Comorbidity-polypharmacy score predicts readmissions in older trauma patients. J Surg Res. 2015;199:237–243. doi: 10.1016/j.jss.2015.05.014.
    1. Jaspers L, Colpani V, Chaker L, van der Lee SJ, Muka T, Imo D, Meindis S, Chowdhury R, Bramer WM, Falla A, Pazoki R, Franco OH. The global impact of non-communicable diseases on households and impoverishment: a systematic review. Eur J Epidemiol. 2015;30:163–188. doi: 10.1007/s10654-014-9983-3.
    1. Justiniano CF, Coffey RA, Evans DC, Jones LM, Jones CD, Bailey JK, Miller SF, Stawicki SP. Comorbidity-polypharmacy score predicts in-hospital compliations and the need for discharge to extended care facility in older burn patients. J Burn Care Res. 2015;36:193–196. doi: 10.1097/BCR.0000000000000094.
    1. Markle-Reid M, Browne G, Weir R, Gafni A, Roberts J, Henderson SR. The effectiveness and efficiency of home-based nursing health promotion for older people: a review of the literature. Med Care Res Rev. 2006;63(5):531–569. doi: 10.1177/1077558706290941.
    1. Markun S, Holzer BM, Rodak R, Kaplan V, Wagner CC, Battegay E, Zimmerli L. Therapeutic conflicts in emergency department patients with multimorbidity: a cross-sectional study. PLoS ONE. 2014;9(10):e110309. doi: 10.1371/journal.pone.0110309.
    1. Nobili A, Pasina L, Tettamenti M, Lucca U, Riva E, Marzona I, Monesi L, Cucchiani R, Bortolutti A, Fortina I, Merlino L, Locatelli W, Giuliani G. Potentially severe drug interactions in elderly outpatients: results of an observational study of an administrative prescription database. J Clin Pharm Ther. 2009;34:377–386. doi: 10.1111/j.1365-2710.2009.01021.x.
    1. Noelker LS, Browdie R. Sidney Katz, MD: a new paradigm for chronic illness and long-term care. The Gerontologist. 2014;54(1):13–20. doi: 10.1093/geront/gnt086.
    1. OECD (2011). Long-term care: growing sector, multifaceted systems. 2011. . Accessed 17 May 2018
    1. Pache B, Vollenweider P, Waeber G, Marques-Vidal P. Prevalence of measured and reported multimorbidity in a representative sample of the Swiss population. BMC Public Health. 2015;15:164. doi: 10.1186/s12889-015-1515-x.
    1. Prados-Torres A, Calderon-Larranaga A, Hancco-Saavedra J, Poblador-Plou B, van den Akker M. Multimorbidity patterns: a systematic review. J Clin Epidemiol. 2014;67:254–266. doi: 10.1016/j.jclinepi.2013.09.021.
    1. Rausch C, Laflamme L, Bültmann U, Möller J. Number of medications and adverse drug events by unintentional poisoning among older adults in consideration of inappropriate drug sue: a Swedish population-based matched case-control study. Eur J Clin Pharmacol. 2017;73:743–749. doi: 10.1007/s00228-017-2220-8.
    1. Rizza A, Kaplan V, Senn O, Rosemann T, Bhend H, Tandjung R. Age- and gender-related prevalence of multimorbidity in primary care: the Swiss FIRE project. BMC Fam Pract. 2012;13:113. doi: 10.1186/1471-2296-13-113.
    1. Rohrer JE, Garrison G, Oberhelman SA, Meunier MR. Epidemiology of polypharmacy among family medicine patients at hospital discharge. J Primary Care Comm Health. 2013;4(2):101–105. doi: 10.1177/2150131912472905.
    1. Skoog J, Midlöv P, Beckman A, Sundquist J, Halling A. Drugs prescribed by general practitioners according to age, gender and socioeconomic status after adjustment for multimorbidity level. BMC Fam Pract. 2014;15:183. doi: 10.1186/s12875-014-0183-8.
    1. Tennstedt SL, McKinlay JB, Sullivan LM. Informal care for frail elders: the role of secondary caregivers. Gerontologist. 1989;29(5):677–683. doi: 10.1093/geront/29.5.677.
    1. Treadwell J. Coping with complexity: working beyond the guidelines for patients with multimorbidities. J Comorbidity. 2015;5:11–14. doi: 10.15256/joc.2015.5.49.
    1. Uijen AA, van de Lisdonk EH. Multimorbidity in primary care: prevalence and trend over the last 20 years. Eur J Gen Pract. 2008;14(suppl. 1):28–32. doi: 10.1080/13814780802436093.
    1. Wauters M, Elseviers M, Vaes B, Degryse J, Dalleur O, van der Stichele R, van Bortel L, Azermai M. Polypharmacy in a Belgian cohort of community-dwelling very elderly (80 +) Acta Clin Belg. 2016;71(3):158–166. doi: 10.1080/17843286.2016.1148298.
    1. Zellweger U, Bopp M, Holzer BM, Djalali S, Kaplan V. Prevalence of chronic medical conditions in Switzerland: exploring estimates validity by comparing complementary data sources. BMC Public Health. 2014;14:1157. doi: 10.1186/1471-2458-14-1157.

Source: PubMed

3
Abonnieren